SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-047919
Filing Date
2024-04-25
Accepted
2024-04-25 07:15:32
Documents
72
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sage-20240331.htm   iXBRL 10-Q 2231790
2 EX-10.1 sage-ex10_1.htm EX-10.1 1094616
3 EX-10.2 sage-ex10_2.htm EX-10.2 33322
4 EX-10.3 sage-ex10_3.htm EX-10.3 87065
5 EX-31.1 sage-ex31_1.htm EX-31.1 10946
6 EX-31.2 sage-ex31_2.htm EX-31.2 10925
7 EX-32.1 sage-ex32_1.htm EX-32.1 8979
8 GRAPHIC img30615032_0.jpg GRAPHIC 160661
9 GRAPHIC img30615032_1.jpg GRAPHIC 117330
10 GRAPHIC img30615032_2.jpg GRAPHIC 136856
11 GRAPHIC img30615032_3.jpg GRAPHIC 117659
12 GRAPHIC img30615032_4.jpg GRAPHIC 11669
13 GRAPHIC img94122402_0.jpg GRAPHIC 134218
  Complete submission text file 0000950170-24-047919.txt   11795793

Data Files

Seq Description Document Type Size
14 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sage-20240331.xsd EX-101.SCH 1237155
76 EXTRACTED XBRL INSTANCE DOCUMENT sage-20240331_htm.xml XML 1811873
Mailing Address 215 FIRST STREET CAMBRIDGE MA 02142
Business Address 215 FIRST STREET CAMBRIDGE MA 02142 617-299-8380
Sage Therapeutics, Inc. (Filer) CIK: 0001597553 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36544 | Film No.: 24872902
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)